Objective measurement of an invisible injury.
Blast overpressure leaves a chemical mark on the brain. DatChem-Blast detects the biomarkers and neural pathways it affects, where imaging alone shows little.
Using two-dimensional Magnetic Resonance Spectroscopy (2D MRS), it assesses repetitive head injuries, giving traumatic brain injury an objective measure.
- Blast-related trauma. Detects the biomarkers of blast overpressure injury.
- Repetitive head injuries. Assessed using two-dimensional MRS (2D MRS).
- Objective measurement. Brings measurement to traumatic brain injury.
What objective measurement makes possible.
Objective TBI measurement
A measured chemical signal brings objectivity to traumatic brain injury.
Repetitive-injury assessment
Assesses repetitive head injuries using two-dimensional MRS (2D MRS).
Defence & sport relevance
Speaks to blast exposure in defence and repetitive head impact in sport.
From scan to report, on existing scanners.
DatChem-Blast adds a two-dimensional MRS sequence to a standard MRI, no new hardware, with results returned to the physician in minutes.
Patient scan
A short 2D MRS scan in a standard MRI captures the raw spectral data, no contrast, no biopsy.
Data capture
Raw data is transmitted securely from the scanner to the DatChem cloud, region by region.
Data processing
The chemical signature is extracted and compared against our exclusive databases.
Physician report
A report identifies the biomarkers and neural pathways affected by blast overpressure.
A completed clinical trial.
A PTSD and blast-overpressure clinical trial has been completed, funded by the USA CTTSO (Combating Terrorism Technical Support Office).
DatChem's technologies are undergoing regulatory evaluation (TGA, FDA and EMA) and are not yet approved for routine clinical use in all markets.
Bring DatChem-Blast to your programme.
For clinical, research or partnership enquiries about DatChem-Blast, we'd be glad to hear from you.